DNA samples obtained from patients enrolled by the Acute Liver Failure Study Group suggest the rs776746 polymorphism in CYP3A5 is associated with increased bioactivation of paracetamol via increased enzyme activity. The gene discussed is CYP3A5; the disease is acute liver failure.